Prasco Launches Authorized Generic of ZIOPTAN® Ophthalmic Solution
MASON, Ohio; November 18, 2022 Prasco Laboratories announced today the launch of the Authorized Generic of ZIOPTAN® (tafluprost ophthalmic solution) 0.0015%. This is Prasco’s first Authorized Generic launch in partnership with Théa Pharma, Inc. Prasco’s Tafluprost...